OpenAI Takes the Lead in AI IPO Race Confidential Filing Expected Soon London Stock Exchange Group Reports Income Growth Led by Tradeweb Platform Markets SixWeek Record Run Top and Bottom Performers in the Club Portfolio Marco Rubio Navigates CubanAmerican Backlash in Pursuit of Economic Engagement with Havana Broadcom Meta Lead 125 Million Semiconductor Research Hub at UCLA IHI Achieves Milestone with First Satellite Imagery from Observation Constellation MDLN Q1 2026 Earnings Earnings Per Share Surpasses Estimates Amid Mixed Market Reaction Lineage Inc LINE Q1 2026 Earnings EPS Miss Sends Shares Higher Amid Operational Strength SoYoung Q1 2026 Earnings EPS Surprises to the Upside Yet Shares Slide AIFF Q3 1998 Earnings Massive EPS Miss as Revenue Remains Unreported Netcapital Inc NCPL Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Operating Environment Kinsale Capital Group Q1 2026 Earnings EPS Surpasses Estimates by 672 ATN International Holds Steady Modest Gains Amidst Key Support and Resistance Levels AngloGold Ashanti AU Slips 145 Gold Miner Hovers Between Key Support and Resistance Riley Exploration Permian REPX Holds Near Key Support After Marginal Decline Tenaya Therapeutics TNYA Edges Higher Biotech Stock Tests Key Resistance at 084 DTE Energy Preferred DTW Holds Steady Near Par Yield Appeal and Technical Support in Focus European AI Stocks Buck Broader Market Gloom Amid Heightened Geopolitical Risks MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns Voya Asia Pacific High Dividend Equity Income Fund IAE Holds Steady at 833 Amid Flat Trading Slide Insurance Holdings Inc SLDE Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Discipline RILYP Q1 2024 Earnings Negative EPS Amid Preferred Stock Challenges NB Q1 2026 Earnings Surprise EPS Beat Amid Development Stage SOMN Q1 2026 Earnings Earnings Beat Estimates Amid Stable Operations CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment DCH Q1 2026 Earnings Massive EPS Surprise Drives Stock Up 39 C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage